In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer,
incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of …

Summary The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on
Clinical Research was held virtually in October, 2021, following published consensus …

Simple Summary Adult granulosa cell tumors (aGCTs) are a rare subtype of ovarian cancer.
First choice of treatment is surgery; when this is not possible, chemotherapy and anti …

Ovarian granulosa cell tumor (GCT) is a rare, low‐grade malignant tumor that accounts for
70% of the sex cord‐stromal tumors. It has two histopathologic types with different clinical …

Background Hormonal therapies are commonly prescribed to patients with metastatic
granulosa cell tumours (GCT), based on high response rates in small retrospective studies …

Aim of the present analysis is to compare the impact of antihormonal therapy versus
cytotoxic chemotherapy versus a watch a wait approach on disease-free survival (DFS) in …

Abstract Adult-type Granulosa Cell Tumor of the Ovary (AGCT) is a relatively rare subtype of
ovarian cancer, accounting for 2-4% of all ovarian cancer. AGCT originates from proliferating …

Non-epithelial cancers arising from the ovary are uncommon malignancies. Germ cell
tumors of the ovary arise from primordial germ cells, and sex cord-stromal tumors of the …

Objective To synthesize the evidence on Sertoli–Leydig cell tumour (SLCT) relapses, and
identify the clinicopathological characteristics and prognosis of patients with recurrent SLCT …

Simple Summary Angiogenesis, defined as the abnormal development of new blood vessels
in cancer, is a key component of cancer development. Clinical trials have proven that …